Patents by Inventor Samuel Earl Hopkins

Samuel Earl Hopkins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GENETIC MARKERS ASSOCIATED WITH RESPONSE TO CYCLOPHILIN-BINDING COMPOUNDS
    Publication number: 20120208746
    Abstract: Methods of predicting the response in a patient infected with hepatitis C virus (HCV) to a treatment regime involving the use of a cyclophilin-binding compound are described which provide for improvements in treatments, pharmaceutical compositions, dosing regimen, assays, kits, and other aspects of the art.
    Type: Application
    Filed: January 12, 2012
    Publication date: August 16, 2012
    Applicant: Scynexis Inc.
    Inventors: Samuel Earl HOPKINS, Yves Joseph Ribeill, Bernard Scorneaux
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20100227801
    Abstract: This invention relates to combinations comprising 3-[(R)-2-(N,N-dimethylamino)ethylthio-Sar]-4-(gammahydroxymethylleucine)cyclosporine, or a pharmaceutically acceptable salt, solvate or hydrate thereof; and certain nucleoside analogues, and their use in the treatment of hepatitis C virus.
    Type: Application
    Filed: January 7, 2010
    Publication date: September 9, 2010
    Applicant: Scynexis, Inc.
    Inventor: Samuel Earl HOPKINS
  • DOSING FORMS AND REGIMENS COMPRISING 3-[(R)-2-(N,N-DIMETHYLAMINO)ETHYLTHIO-SAR]-4-(GAMMAHYDROXYMETHYLLEUCINE)CYCLOSPORINE
    Publication number: 20100173837
    Abstract: Provided herein are specific doses of, and dosing regimens for, using SCY-635 in treating or preventing diseases, in particular hepatitis C virus (HCV) infection.
    Type: Application
    Filed: January 7, 2010
    Publication date: July 8, 2010
    Applicant: Scynexis, Inc.
    Inventor: Samuel Earl Hopkins
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20080255038
    Abstract: This invention relates to a compound of general formula (I): wherein A, B, R1, R2 and X are as defined in the specification, and pharmaceutical compositions prepared from the same, in combination with one or more NS5B polymerase inhibitors, for use in treatment of hepatitis C virus.
    Type: Application
    Filed: April 10, 2008
    Publication date: October 16, 2008
    Inventors: Samuel Earl Hopkins, Michael Robert Peel